Compile Data Set for Download or QSAR
Report error Found 57 Enz. Inhib. hit(s) with all data for entry = 50017479
TargetTransient receptor potential cation channel subfamily M member 4(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602147(CHEMBL5209164)
Affinity DataEC50:  2.63E+4nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602160(CHEMBL5179994)
Affinity DataEC50:  316nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602161(CHEMBL5184410)
Affinity DataEC50:  1.00E+3nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602162(CHEMBL5194924)
Affinity DataEC50:  100nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602163(CHEMBL5189636)
Affinity DataEC50:  200nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602164(CHEMBL5186500)
Affinity DataEC50:  200nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602165(CHEMBL5193084)
Affinity DataEC50:  63nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602166(CHEMBL5203756)
Affinity DataEC50:  2.00E+3nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602167(CHEMBL5194127)
Affinity DataEC50:  3.16E+3nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602168(CHEMBL5192928)
Affinity DataEC50:  126nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602169(CHEMBL5186666)
Affinity DataEC50:  7.94E+3nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602170(CHEMBL5188072)
Affinity DataEC50:  251nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602168(CHEMBL5192928)
Affinity DataEC50:  125nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602171(CHEMBL5175507)
Affinity DataEC50:  2.00E+4nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 4(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602141(CHEMBL5175850)
Affinity DataEC50:  2.45E+4nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602159(CHEMBL5202815)
Affinity DataEC50:  501nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 4(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602159(CHEMBL5202815)
Affinity DataEC50:  1.82E+3nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 4(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602160(CHEMBL5179994)
Affinity DataEC50:  1.70E+3nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 4(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602161(CHEMBL5184410)
Affinity DataEC50:  2.57E+4nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 4(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602162(CHEMBL5194924)
Affinity DataEC50:  1.35E+3nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 4(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602163(CHEMBL5189636)
Affinity DataEC50:  8.91E+3nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 4(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602164(CHEMBL5186500)
Affinity DataEC50:  589nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 4(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602168(CHEMBL5192928)
Affinity DataEC50:  1.15E+4nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 4(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602168(CHEMBL5192928)
Affinity DataEC50:  1.14E+4nMAssay Description:Agonist activity at human TRPM4 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit by measuring membrane potential by FLIPR...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Mouse)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602168(CHEMBL5192928)
Affinity DataEC50:  251nMAssay Description:Agonist activity at mouse TRPM5 expressed in CHO-K1 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily V member 1(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602168(CHEMBL5192928)
Affinity DataEC50: <1.58E+4nMAssay Description:Agonist activity at human TRPV1More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 8(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602168(CHEMBL5192928)
Affinity DataEC50: <1.58E+4nMAssay Description:Agonist activity at human TRPM8 expressed in HEK cells assessed as increase in intracellular calcium level measured for 5 mins by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily A member 1(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602168(CHEMBL5192928)
Affinity DataEC50: <1.58E+4nMAssay Description:Agonist activity at human TRPA1 expressed in HEK cells assessed as increase in intracellular calcium level measured for 5 mins by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily V member 4(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602168(CHEMBL5192928)
Affinity DataEC50: <1.58E+4nMAssay Description:Agonist activity at human TRPV4More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602158(CHEMBL5169709)
Affinity DataEC50:  1.59E+3nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602135(CHEMBL5209032)
Affinity DataEC50:  9.40E+3nMAssay Description:Agonist activity at human TRPM5 expressed in HEK cells by whole cell electrophysiology methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602138(CHEMBL3577084)
Affinity DataEC50:  2.70E+4nMAssay Description:Agonist activity at human TRPM5 in HEK293T cells by FLIPR based assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50571573(CHEMBL4863993)
Affinity DataEC50:  7.90nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602135(CHEMBL5209032)
Affinity DataEC50:  631nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602139(CHEMBL5174768)
Affinity DataEC50: <3.16E+4nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602140(CHEMBL5183134)
Affinity DataEC50: <3.16E+4nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602140(CHEMBL5183134)
Affinity DataEC50: <3.16E+4nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602141(CHEMBL5175850)
Affinity DataEC50:  794nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602142(CHEMBL5184511)
Affinity DataEC50: <3.16E+4nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602143(CHEMBL5204424)
Affinity DataEC50: <3.16E+4nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602144(CHEMBL5206442)
Affinity DataEC50: <3.16E+4nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602145(CHEMBL5206953)
Affinity DataEC50:  1.58E+4nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602146(CHEMBL5177026)
Affinity DataEC50:  50nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602147(CHEMBL5209164)
Affinity DataEC50:  501nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602148(CHEMBL5181952)
Affinity DataEC50:  316nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602149(CHEMBL5175871)
Affinity DataEC50:  1.26E+3nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602150(CHEMBL5191331)
Affinity DataEC50: <3.16E+4nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602151(CHEMBL5172970)
Affinity DataEC50:  1.00E+4nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602152(CHEMBL5198954)
Affinity DataEC50:  1.00E+4nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetTransient receptor potential cation channel subfamily M member 5(Human)
Turning Point Therapeutics

Curated by ChEMBL
LigandPNGBDBM50602153(CHEMBL5196346)
Affinity DataEC50: <3.16E+4nMAssay Description:Agonist activity at human TRPM5 expressed in CHO-K1 cells assessed as increase in relative fluorescence unit measured for 2 mins by FLIPR based membr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
Displayed 1 to 50 (of 57 total ) | Next | Last >>
Jump to: